FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890795745> ?p ?o ?g. }

• W2890795745 endingPage "e0203452" @default.
• W2890795745 startingPage "e0203452" @default.
• W2890795745 abstract "Simplification strategies of antiretroviral treatment represent effective tools for the reduction of drug-induced toxicity, resistance mutations in case of virological failure and costs.To assess the effectiveness of simplification to atazanavir/ritonavir (ATVrtv) or unboosted atazanavir (ATV400) plus lamivudine, and if low plasma or intracellular ATV Ctrough influence virological outcomes.Ambispective observational study in patients with undetectable HIV-RNA who were switched to ATVrtv or ATV400 plus lamivudine once daily. Previous virological failures (VF) were allowed if the resistance tests showed major resistance mutation neither to ATV nor to lamivudine. VF was defined as two consecutive plasma HIV-RNA >200 copies/mL. Effectiveness was assessed by intention-to-treat and on-treatment analyses. Plasma and intracellular ATV Ctrough were measured by LC-MS/MS.A total of 246 patients were included. At week 48, the Kaplan-Meier estimation of efficacy within the ATVrtv and ATV400 groups were 85.9% [95% confidence interval, (CI95), 80.3-91.4%] versus 87.6% (CI95, 80.1-94.1%) by intention-to-treat analysis (p = 0.684), and 97.7% (CI95, 95.2-100%) versus 98.8% (CI95, 97.0-100%) by on-treatment analysis (p = 0.546), respectively. Plasma and intracellular Ctrough were significantly higher with ATVrtv than with ATV400 (geometric mean (GM), 318.3 vs. 605.9 ng/mL; p = 0.013) and (811.3 vs. 2659.2 ng/mL; p = 0.001), respectively. Only 14 patients had plasma Ctrough below the suggested effective concentration for ATV (150 ng/mL). No relationship between plasma or intracellular Ctrough and VF or blips were found.Boosted or unboosted ATV plus lamivudine is effective and safe, and the lower plasma Ctrough observed with ATV400 do not compromise the effectiveness of these simplification regimens in long-term virologically suppressed HIV-1-infected patients." @default.
• W2890795745 created "2018-09-27" @default.
• W2890795745 creator A5003776429 @default.
• W2890795745 creator A5004926416 @default.
• W2890795745 creator A5028249068 @default.
• W2890795745 creator A5047687363 @default.
• W2890795745 creator A5058087524 @default.
• W2890795745 creator A5080754332 @default.
• W2890795745 creator A5082486861 @default.
• W2890795745 creator A5085827998 @default.
• W2890795745 date "2018-09-20" @default.
• W2890795745 modified "2023-10-16" @default.
• W2890795745 title "No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients" @default.
• W2890795745 cites W1544659534 @default.
• W2890795745 cites W1970937993 @default.
• W2890795745 cites W1976641979 @default.
• W2890795745 cites W1980690358 @default.
• W2890795745 cites W1988101744 @default.
• W2890795745 cites W1988633664 @default.
• W2890795745 cites W1996364592 @default.
• W2890795745 cites W2025133320 @default.
• W2890795745 cites W2032959558 @default.
• W2890795745 cites W2065271211 @default.
• W2890795745 cites W2071792381 @default.
• W2890795745 cites W2072666308 @default.
• W2890795745 cites W2096488034 @default.
• W2890795745 cites W2099015360 @default.
• W2890795745 cites W2103798805 @default.
• W2890795745 cites W2106383584 @default.
• W2890795745 cites W2147357250 @default.
• W2890795745 cites W2149904066 @default.
• W2890795745 cites W2150597734 @default.
• W2890795745 cites W2155787419 @default.
• W2890795745 cites W2162562317 @default.
• W2890795745 cites W2170220851 @default.
• W2890795745 cites W2254214692 @default.
• W2890795745 cites W2277219070 @default.
• W2890795745 cites W2313623892 @default.
• W2890795745 cites W2317747011 @default.
• W2890795745 cites W2337376130 @default.
• W2890795745 cites W2414699286 @default.
• W2890795745 cites W2509377447 @default.
• W2890795745 cites W2579301883 @default.
• W2890795745 cites W2615368970 @default.
• W2890795745 cites W2772346457 @default.
• W2890795745 cites W2788591875 @default.
• W2890795745 doi "https://doi.org/10.1371/journal.pone.0203452" @default.
• W2890795745 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6147473" @default.
• W2890795745 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30235244" @default.
• W2890795745 hasPublicationYear "2018" @default.
• W2890795745 type Work @default.
• W2890795745 sameAs 2890795745 @default.
• W2890795745 citedByCount "2" @default.
• W2890795745 countsByYear W28907957452021 @default.
• W2890795745 countsByYear W28907957452022 @default.
• W2890795745 crossrefType "journal-article" @default.
• W2890795745 hasAuthorship W2890795745A5003776429 @default.
• W2890795745 hasAuthorship W2890795745A5004926416 @default.
• W2890795745 hasAuthorship W2890795745A5028249068 @default.
• W2890795745 hasAuthorship W2890795745A5047687363 @default.
• W2890795745 hasAuthorship W2890795745A5058087524 @default.
• W2890795745 hasAuthorship W2890795745A5080754332 @default.
• W2890795745 hasAuthorship W2890795745A5082486861 @default.
• W2890795745 hasAuthorship W2890795745A5085827998 @default.
• W2890795745 hasBestOaLocation W28907957451 @default.
• W2890795745 hasConcept C126322002 @default.
• W2890795745 hasConcept C142462285 @default.
• W2890795745 hasConcept C159047783 @default.
• W2890795745 hasConcept C2522874641 @default.
• W2890795745 hasConcept C2777351918 @default.
• W2890795745 hasConcept C2777869810 @default.
• W2890795745 hasConcept C2778414717 @default.
• W2890795745 hasConcept C2779298103 @default.
• W2890795745 hasConcept C2780593183 @default.
• W2890795745 hasConcept C2993143319 @default.
• W2890795745 hasConcept C3013748606 @default.
• W2890795745 hasConcept C44249647 @default.
• W2890795745 hasConcept C71924100 @default.
• W2890795745 hasConcept C90924648 @default.
• W2890795745 hasConcept C98274493 @default.
• W2890795745 hasConceptScore W2890795745C126322002 @default.
• W2890795745 hasConceptScore W2890795745C142462285 @default.
• W2890795745 hasConceptScore W2890795745C159047783 @default.
• W2890795745 hasConceptScore W2890795745C2522874641 @default.
• W2890795745 hasConceptScore W2890795745C2777351918 @default.
• W2890795745 hasConceptScore W2890795745C2777869810 @default.
• W2890795745 hasConceptScore W2890795745C2778414717 @default.
• W2890795745 hasConceptScore W2890795745C2779298103 @default.
• W2890795745 hasConceptScore W2890795745C2780593183 @default.
• W2890795745 hasConceptScore W2890795745C2993143319 @default.
• W2890795745 hasConceptScore W2890795745C3013748606 @default.
• W2890795745 hasConceptScore W2890795745C44249647 @default.
• W2890795745 hasConceptScore W2890795745C71924100 @default.
• W2890795745 hasConceptScore W2890795745C90924648 @default.
• W2890795745 hasConceptScore W2890795745C98274493 @default.
• W2890795745 hasIssue "9" @default.
• W2890795745 hasLocation W28907957451 @default.
• W2890795745 hasLocation W28907957452 @default.

• next